# Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

> **NCT02590367** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Jiangsu Province Hospital of Traditional Chinese Medicine** · enrollment: 64 (estimated)

## Conditions studied

- Peripheral Neuropathy

## Interventions

- **DRUG:** FOLFOX regimen
- **DRUG:** HD6610 Granule
- **DRUG:** HD6610 Granule placebo

## Key facts

- **NCT ID:** NCT02590367
- **Lead sponsor:** Jiangsu Province Hospital of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590367, "Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02590367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*